KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Non-Current Assets (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Non-Current Assets data on record, last reported at -$1.4 billion in Q4 2025.

  • For Q4 2025, Non-Current Assets fell 174.67% year-over-year to -$1.4 billion; the TTM value through Dec 2025 reached -$2.3 billion, down 318.55%, while the annual FY2025 figure was -$1.4 billion, 174.67% down from the prior year.
  • Non-Current Assets reached -$1.4 billion in Q4 2025 per IDXX's latest filing, down from -$1.4 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.9 billion in Q1 2025 and bottomed at -$1.4 billion in Q3 2024.
  • Average Non-Current Assets over 5 years is $598.4 million, with a median of $1.6 billion recorded in 2021.
  • Peak YoY movement for Non-Current Assets: soared 260.76% in 2023, then tumbled 184.23% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $1.5 billion in 2021, then rose by 11.05% to $1.6 billion in 2022, then grew by 7.26% to $1.8 billion in 2023, then grew by 7.3% to $1.9 billion in 2024, then tumbled by 174.67% to -$1.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were -$1.4 billion in Q4 2025, -$1.4 billion in Q2 2025, and $1.9 billion in Q1 2025.